Trial Profile
Safety, pharmacokinetics, and pharmacodynamics study of MK-8389 in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs MK 8389 (Primary)
- Indications Infertility
- Focus Adverse reactions; Pharmacokinetics
- 04 Feb 2016 New trial record
- 05 Jan 2016 Results published in the Fertility and Sterility